Page URL:

Heart attack stem cell trials inconclusive

25 September 2006
Appeared in BioNews 377

Three new studies published in the New England Journal of Medicine (NEJM) reveal contradictory results following the use of bone marrow-derived stem cells to treat heart attack patients. Two of reports found that injections of a patient's own bone marrow cells can improve heart function after a heart attack, while a third study showed no effect. An accompanying editorial by deputy NEJM editor Dr Robert Schwartz warns that these inconclusive results 'will probably not stop the exploitation of patients with promises that bone marrow (or cord blood) can cure almost any chronic disease'.

Heart attacks damage the heart muscle and associated blood vessels, which stop it working effectively. Previous research suggested that injections of stem cells derived from bone marrow can trigger the growth of new heart muscle, although scientists do not clearly understand how this happens. According to cardiologist Andreas Zeiher of the University of Frankfurt - and leader of two of the trials - the '$100 million question' is whether certain types of bone marrow cell are more effective at cardiac repair than others.

In one of the trials, Zeiher and his colleagues studied 204 volunteers who had suffered a heart attack within the previous week, and a further 75 who had been affected more than six years earlier. Half of the new patients were given an injection of their own bone marrow into the affected artery, while the others received a placebo injection. Four months after treatment, the heart-pumping capacity (measured as 'left ventricular ejection fraction') of the treated participants was 2.5 per cent better than the control group's. A year later, two of the treated patients had died, but none had suffered another heart attack, compared to six deaths and five further heart attacks in the control group.

The study of patients who had suffered heart attacks more than six years previously showed that patients given an injection of bone marrow cells had an improved pumping efficiency of 4.1 per cent. Another group who received injections of blood cells, rather than bone marrow, showed no benefit. A third study, published by scientists based at the Rikshospitalet in Oslo, Norway, also showed no beneficial effect. However, the study was not designed to pick up differences in pumping efficiency of less than five per cent - the minimum improvement team leader Ketil Lunde felt was necessary to justify the invasive procedure.

Zeiher is now planning a trial of a further 1200 patients. Commenting on the recent studies, US cardiologist Joshua Hare told the journal Science: 'I don't think the data's strong enough to say we should start doing this to everybody', adding, 'but it clearly substantiates that we should move ahead'. In his editorial, Dr Schwartz praised the researchers for carrying out 'very difficult studies', but also cautioned that the studies provided no evidence that the injected cells actually became cardiac myocytes (heart muscle cells).

Adult Stem Cells Help Weakened Hearts
New Scientist |  21 September 2006
A Shot of Bone Marrow Can Help the Heart
Science |  22 September 2006
The Politics and Promise of Stem-Cell Research
New England Journal of Medicine |  21 September 2006
13 June 2011 - by Dr Sophie Pryor 
A naturally occurring protein can activate stem cells in mouse hearts, producing new muscle cells to replace the tissue damaged by a heart attack, UK scientists have found...
28 April 2008 - by Evelyn Harvey 
Two men were the first subjects of a groundbreaking clinical research trial to establish the efficacy of treating patients with stem cells from their own bone marrow hours after a heart attack. The randomised controlled trial, the first to be supported by the UK Stem Cell Foundation...
13 October 2005 - by BioNews 
Doctors based at Barts and the London NHS Trust have launched a trial to test if heart damage can be effectively treated using stem cells taken from a patient's own bone marrow. The study will involve 700 patients, and will look at three different types of heart damage. The trial...
26 July 2005 - by BioNews 
Doctors think they are close to treating heart attack victims with stem cells, after promising results in trials using pigs. A Phase I clinical trial on 48 patients is set to begin soon in the US to test the safety of the procedure in humans. The procedure involves injecting people...
11 February 2005 - by BioNews 
US researchers have discovered that the heart contains a type of stem cell that can divide and produce new heart cells after birth, which might allow the organ to repair itself. The surprise finding could lead to new therapies for damage caused by heart attacks. The researchers, based at the...
4 February 2005 - by BioNews 
A new type of stem cell isolated from human bone marrow could have all the medical potential of embryonic stem (ES) cells, US researchers say. However, not all scientists are convinced of that the cells are as versatile as they appear to be, according to a report in the Washington...
9 July 2004 - by BioNews 
Stem cells boost the recovery of damaged hearts, German researchers have found. A report, published in the journal The Lancet, reveals that stem cells taken from the bone marrow increase the efficiency of hearts that have been damaged by heart attacks. The way in which this works still remains unclear...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.